about
Impact of soluble epoxide hydrolase and epoxyeicosanoids on human healthEpoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular functionRole of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionInside epoxyeicosatrienoic acids and cardiovascular diseaseCytochrome P450 eicosanoids in hypertension and renal diseaseTargeting epoxides for organ damage in hypertensionSoluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitorEpoxyeicosatrienoic acids, hypertension, and kidney injuryCytochrome P450 eicosanoids and cerebral vascular functionEpoxides and soluble epoxide hydrolase in cardiovascular physiologyEpoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition.Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.The role of epoxide hydrolases in health and disease.Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actionsApplication of fullerenes in nanomedicine: an update.Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive ratsAryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvesselsInhibiting an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa Protects CFTR.Vascular pharmacology of epoxyeicosatrienoic acidsMyocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency.Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndromePlasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.Microsomal cytochrome P450 as a target for drug discovery and repurposing.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in miceAsymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.Epoxyeicosatrienoic Acid Inhibits the Apoptosis of Cerebral Microvascular Smooth Muscle Cells by Oxygen Glucose Deprivation via Targeting the JNK/c-Jun and mTOR Signaling Pathways.Specific plasma oxylipins increase the odds of cardiovascular and cerebrovascular events in patients with peripheral artery disease.The protective effect of epoxyeicosatrienoic acids on cerebral ischemia/reperfusion injury is associated with PI3K/Akt pathway and ATP-sensitive potassium channels.Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing.
P2860
Q24618018-D2B6B3AC-1D4E-4BD2-8533-E832C111F415Q26849271-82096B66-8544-491B-9114-F1A7B9BB36A6Q27000348-5A5A2F32-4E99-4C0C-9299-196473CDDEEEQ28252156-59A27A73-761F-42E6-9D0B-EA5B4E9FDD25Q28252210-D50C147C-2058-4DDC-B37C-BBAE4FE80D9DQ28387558-294BAA71-9B4D-4AC0-B645-E05818B1A086Q28387686-39D1562A-C968-4300-9EBC-432E3E79FE39Q28387823-C1B7357E-941F-42DB-906E-694AC192892FQ28396302-A4D8605C-8B00-4F64-99FF-8ADF90550DF5Q28396313-BAB2E014-A894-4A04-95C1-55C137DB6EFAQ33854978-50DAFB09-6A6E-46FD-AB78-ED3BE9091B7FQ33904690-8AEC2BF6-2EA2-4E6F-B94E-CF7F8CE6B73FQ33939653-42F65B3C-DB41-4462-919B-528A84C40491Q34229608-E2D25D32-7583-4432-81C5-38AC0D57D924Q34440084-F9D6496B-655C-446C-A47A-A8269E2BB196Q34691742-872D2247-DA23-4A7F-A327-A85FF3FDE994Q34803596-3FC6548E-8A6B-4DF7-8871-5C5583D92199Q35057234-C7B97604-7AAA-47F2-A4CC-299ADE0F1FDFQ35232729-D3111E49-381A-42B3-A3B7-7B58FBB0D1A8Q35681388-7399AD0E-3D81-4192-A79D-7A38065BE4DFQ36027183-6CE9551B-FCCC-4845-BF92-3D925F2766E0Q36127040-559086E5-0854-42FC-94DF-19BE587E323DQ36483036-32CAD701-4E26-4D01-A80B-E49F7745C930Q36502405-5D374C10-B1F2-4598-849C-BFD614F69136Q36754802-0EC46066-974D-4104-B865-C2EBA87AACE0Q36822568-00DAE6E9-40EF-41C9-BAE9-FB30C424C68FQ38138158-30D1F4BA-65DA-4BBC-B735-A6090EFA664FQ38693289-20F1C32C-A703-4146-8218-59B6DDE6C1A3Q39000644-DAF402F6-5A90-415E-9BD0-36B94E739DCBQ39249384-CCBC1615-B5E1-42C4-8184-F62F2C9C8E55Q39392465-CC604971-A0CF-4976-9D77-40BE97DC2C56Q41354081-C6AAD0D0-AD09-45D6-BD65-91BEB2E38C07Q41429574-74D71639-337A-4B37-B49E-6C3C5CF439D7Q42580116-9DD34EEB-282D-4632-8236-8D7FB61FE0BFQ44027147-B4D6FF1D-E7DF-4961-B8F0-BA24D0A65600Q47447000-53F71989-79B3-4D8F-8E60-24D21A76B16CQ47696134-9DD471B8-AD0E-478D-9FCE-4AAFE23637DFQ48467605-4DC55DEF-086D-4404-9F60-90BEDFD417DFQ51057431-5C547B9D-1142-4673-B8EC-F7F7B81DBD17
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epoxyeicosatrienoic acid analogs and vascular function.
@en
Epoxyeicosatrienoic acid analogs and vascular function.
@nl
type
label
Epoxyeicosatrienoic acid analogs and vascular function.
@en
Epoxyeicosatrienoic acid analogs and vascular function.
@nl
prefLabel
Epoxyeicosatrienoic acid analogs and vascular function.
@en
Epoxyeicosatrienoic acid analogs and vascular function.
@nl
P2093
P2860
P1476
Epoxyeicosatrienoic acid analogs and vascular function.
@en
P2093
P2860
P304
P356
10.2174/092986710790827843
P577
2010-01-01T00:00:00Z